Note: Ingredients listed on restricted chemical lists
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
N/A
EC/CAS
215-609-9
Name of the chemical
Carbon black
Concentration
N/A
General Information
Revision date
2009-05-29
Product name
Black Toner for FS-C1020MFP
CAS No.
1333-86-4
supplier name
KYOCERA MITA Europe B.V
Manufacturer Name
KYOCERA MITA CORPORATION
Icons in SDS
Company Information
company name
KYOCERA MITA Europe B.V
Section 2
Potential health effects
There are no significant hazards expected with intended use.
Environmental effects
There are no significant hazards expected with intended use.
Other physicochemical hazards
There are no significant hazards expected with intended use. Specific Hazards Dust explosion (like most finely grained organic powders) Main Symptoms Acute Inhalation Toxicity Exposure to excessive amount of dust may cause physical irritation to respiratory tract . Acute Oral Toxicity Low acute toxicity in animal experiment. Acute Eye Irritation May cause slight transient irritation. Acute Skin Irritation May be non-irritant. Sensitization From test no apparent significant hazards are expected . (Only few cases reported on inci- dental allergy-related conjunctivitis or dermatitis.)
Potential chronic health
Slight pulmonary fibrosis has been reported in rats upon chronic inhalation exposure to a toner at 4mg/m3 every day for 2 years. No pulmonary change was found at 1mg/m3. These findings show that exposure to excessive amounts of powder may cause damage to lungs . However, normal use and handling of this product as intended, does not result in inhalation of excessive amounts of powder. Carcinogenicity Carbon black contained in this product is classified to Group 2B of IARC as the result of inha- lation test in use of rat. But oral/skin test does not show carcinogenicity. The toner containing carbon black did not show carcinogenicity in chronic inhalation exposure test in use of rat. The Classification of The Chemical Product This preparation is not classified as dangerous according to Directive 1999/45/EC.